Change Management in Argentina: ANMAT Notification and 8799/2025 Duties
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Change management in Argentina runs on two parallel tracks:
At the product level, any modification must be notified to ANMAT within 30 working days of implementation, and for matters requiring prior approval, nothing may be disclosed to the market before official publication. Major changes, such as relocation of the manufacturing site, major design or material changes, or expansion of indications, may require supplementary documentation under the original registration requirements and, in extreme cases, re-registration.
At the company qualification level, companies using the Disposición 8799/2025 simplified pathway must replace the original sworn declaration with a new one within 30 days whenever any information changes, including company name, legal address, newly added premises, change of manufacturer, or change of technical director.
The two tracks differ in clock, scope, and consequence, and a change process that conflates them will miss one while satisfying the other. Product changes are measured in working days and can trigger supplementary documentation; company qualification changes are measured in calendar days and are handled through replacement declarations. Both are strict, and both start from the moment the change is real, not the moment the paperwork catches up.
Neither track allows a company to wait for regulatory questions before acting. The notification of product changes is a proactive duty with its own working-day clock, and the replacement of sworn declarations on the 8799/2025 pathway is likewise initiated by the company, not requested by ANMAT. In both cases, the filing itself is the compliance; there is no approval step that conveniently coincides with the deadline. Companies should therefore treat the change log as a regulatory artifact in its own right: maintained in real time, reconciled against shipped product and current declarations, and auditable internally on demand.
2. Legal basis
| Regulation | Reference / number | Publication date | Provisions |
|---|---|---|---|
| MERCOSUR technical regulation on medical device registration | GMC/RES 25/21 | October 13, 2021 | Change notification provision; Part IV (information consistency) |
| Domestic transposition instrument | Disposición ANMAT 64/2025 | Published January 13, 2025 in the Official Gazette | Change provisions |
| Simplified company qualification pathway for low-risk entities | Disposición ANMAT 8799/2025 | Published November 28, 2025; effective 60 administrative working days after publication | 30-day change notification provision |
| Principal product registration regulation | Disposición ANMAT 64/2025 | January 13, 2025 | Re-registration provision |
3. Expert insights
Insight 1: The 30 working days run from implementation, not from decision. This means that the moment a change lands commercially, for example products shipping under the new design or labels already swapped, the notification clock starts immediately. Companies accustomed to a practice of change first and report later will accumulate a continuous compliance exposure in Argentina. There is no allowance for internal rollout schedules, no grace period while stock sells through, and no argument that the change was gradual. If implementation is staggered, each implemented element starts its own clock, and the only defensible posture is to notify within the window from the earliest implementation date.
Insight 2: The dividing line between major and ordinary changes is whether supplementary documentation is needed. The text does not provide an explicit list-style definition; the substantive test is whether the change affects the conclusions on safety and effectiveness of the product. Four categories are high-risk changes: design, materials, manufacturing site, and indications. Minor label wording adjustments and packaging format changes are low-risk changes. When in doubt, treat the change as major. This default is not overcautious; it aligns with how ANMAT evaluates filings, and under-notifying a major change is far harder to remediate than over-notifying an ordinary one.
Insight 3: An approved change does not reset the registration clock. The product retains its original validity period and expiry date. This matters especially for continuously iterating SaMD, where version management must be bound to the registration ledger: which model version corresponds to which registration number, and which modifications constitute notifiable changes, must be clear internally. Without that mapping, a software roadmap and a regulatory dossier drift apart silently, and the company discovers at renewal or inspection that the market contains versions never assessed.
Insight 4: Change control is where post-market compliance quietly connects back to registration. Every notifiable change that is properly filed keeps the registration record aligned with the product actually on the market; every change that slips creates a divergence that later surfaces during inspections, renewals, or vigilance investigations, when the filed description no longer matches the device being assessed. Because Argentina measures the 30 working days from implementation, the connection must be built into the release process itself rather than handled as a follow-up correspondence task. In practice, the strongest control is organizational: the person who authorizes implementation of a change should be different from the person who files the notification, so that the act of shipping and the act of notifying check each other continuously.
4. Practical recommendations
- Build a change classification matrix. Sort changes in seven categories, namely design, materials, process, manufacturing site, indications, labels, and packaging, into major and ordinary tiers, and write down the handling path for each tier.
- Hook the notification action to the implementation milestone. Make notifying ANMAT a mandatory node in the change implementation workflow, completed within 30 working days of implementation.
- Maintain a version-to-registration-number ledger for SaMD. Define the mapping between model weights, decision thresholds, software versions, and registration numbers, and delineate which updates constitute notifiable changes.
- Set five change trigger points for companies on the 8799/2025 pathway. Name, legal address, newly added premises, change of manufacturer, and technical director: any of these changes requires a new sworn declaration within 30 days.
5. Verification checklist
- □ A classification matrix for the seven change categories has been established
- □ The notification action has been hooked into the change implementation workflow
- □ It has been confirmed that the 30 working days run from the implementation date
- □ A supplementary documentation plan for major changes, namely manufacturing site, design and materials, and indications, has been prepared
- □ A version-to-registration-number ledger for SaMD has been established
- □ The five-change trigger mechanism for companies on the 8799/2025 pathway has been set up
- □ Changes requiring prior approval have been confirmed as undisclosed to the market before official publication
Regulatory information verified as of October 29, 2026.
In Argentina, GRZAN operates a wholly owned subsidiary that can act as the registration holder and importer for foreign manufacturers, directly handling classification assessment, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and label localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance, and 5-year renewal planning.
The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience, tracking the developments of regulators worldwide. All external content follows the drafting standard of conclusions first, traceable basis, and verifiable numbers. For a market access plan tailored to your specific product for Argentina or the MERCOSUR region, contact the GRZAN regulatory team at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us